← Browse by Condition
Medical Condition

relapsing multiple sclerosis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06617793 Phase 1, Phase 2
Recruiting

An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis

Enrollment
28 pts
Location
Australia, France, G...
Sponsor
Novartis Pharmaceuticals
View Trial →